FDA Approved: BIVALIRUDIN — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approves Dr. Reddy's Laboratories Limited's supplemental application for Bivalirudin, a generic anticoagulant, under an ANDA. The approval covers its use to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Bivalirudin (bivalirudin)

Snippet

SUPPL AP for BIVALIRUDIN (BIVALIRUDIN)